The Periodontal Therapeutics Market was valued at USD 859.13 million in 2023 and is expected to reach USD 1666.11 million by 2032, growing at a CAGR of 7.62% from 2024-2032.
To Get more information on Periodontal Therapeutics Market - Request Free Sample Report
This report provides insights into the Periodontal Therapeutics Market by including unique statistical analysis and trend assessment. It provides comprehensive data on periodontal disease incidence and prevalence, including regional differences in disease burden. The research also delves into prescription trends geographically, reflecting differences in therapeutic strategies and product choice. It analyzes drug and product use trends, giving a long-term outlook of market change. The report also discusses healthcare expenditure on periodontal treatment by region, along with technological innovations influencing treatment effectiveness and delivery.
The U.S. Periodontal Therapeutics Market was valued at USD 246.62 million in 2023 and is expected to reach USD 471.30 million by 2032, growing at a CAGR of 7.30% from 2024-2032. The United States established its position as the leading country in the North American periodontal therapeutics market due to the significant prevalence of periodontal diseases among the adult population. High dental infrastructure in the country, higher awareness towards oral health, and favorable public health programs are among the significant factors that helped the country establish itself as a leading player in the region.
Drivers
The rising prevalence of periodontal diseases across the globe is a major growth driver for the periodontal therapeutics market.
Severe periodontal disease impacts almost 20% of the adult population in the world, with increased prevalence among the elderly, reports the Global Burden of Disease Study 2023. Risk factors include poor oral hygiene, smoking, diabetes, and advancing age. As populations further age, particularly in developed world regions like Europe and North America, demand is anticipated to expand for targeted treatment. Furthermore, increased awareness of the systemic association between periodontal disease and other chronic ailments like cardiovascular disease and diabetes has resulted in heightened demand for prompt diagnosis and treatment. This has spurred greater funding for research, public health initiatives, and professional education in periodontal care, directly impacting the market growth.
Technological advances in drug formulations and targeted delivery systems are transforming the periodontal therapeutics market.
Localized delivery systems—gels, microspheres, and biodegradable chips loaded with antibiotics or antiseptics—have significantly improved treatment by focusing the therapeutic effect at the site of disease while reducing systemic side effects. For instance, drugs such as Arestin (minocycline microspheres) and PerioChip (chlorhexidine chip) have shown great efficacy in reducing periodontal pocket depth and enhancing gingival health. New R&D has also focused on nanotechnology-based delivery systems for controlled drug release and enhanced tissue regeneration. Additionally, new combinations of anti-inflammatory and antimicrobial agents are being launched to treat complex periodontal diseases more effectively. These innovations are helping drive both improved clinical outcomes and wider usage by dental professionals, facilitating market growth.
Restraint
High cost and limited reimbursement for advanced periodontal therapies are restraining the market growth.
One of the key constraints in the periodontal therapeutics market is the exorbitant cost of using advanced treatment technologies, along with inadequate reimbursement coverage, particularly in low- and middle-income economies. New drug delivery systems and specialty therapeutics, although effective, tend to be priced at a premium and are thus not affordable for many patients. Providers of insurance in various areas do not cover periodontal therapy to the full amount unless medically warranted, which disincentivizes early treatment and regular application of these therapies. The American Dental Association states that a large proportion of periodontal procedures are paid out of pocket, causing an additional financial load on patients. This financial impediment is of particular concern where dental care does not form part of national health plans. Consequently, patients can choose low-level treatments or forego care altogether, which limits therapeutic adoption and market penetration.
Opportunities
Integration of Periodontal Care in Systemic Disease Management presents a significant opportunity for the market.
Increasing evidence of the association between periodontal disease and systemic health conditions like diabetes, cardiovascular disease, and pregnancy complications offers a compelling opportunity in the periodontal therapeutics market. With healthcare systems shifting more towards holistic and preventive care, the inclusion of periodontal therapy in chronic disease management programs could boost demand. For example, research has indicated that treating periodontal disease can enhance glycemic control in diabetic patients. Such linkages foster interdisciplinary treatment paradigms, inspiring general practitioners and specialists to send patients for periodontal therapy. Moreover, public health policy and insurance organizations are starting to acknowledge the systemic effects of oral health, possibly triggering increased coverage and enhanced access. Such synergy would expand therapeutic scope, capture non-traditional prescribers, and drive a solid demand for complex periodontal products and custom care protocols.
Challenges
Patient Compliance and Awareness Gaps are challenging the market growth.
A recurring issue in the periodontal therapeutics market is poor patient compliance with prescribed treatment regimens and poor awareness of the severity of periodontal disease. Most patients are not aware that periodontal disease may advance silently, without pain, and hence, diagnosis and treatment are delayed. Even after diagnosis, long-term maintenance therapy and adjunctive drug use demand high compliance, which is often not available. Based on international oral health reports, a large number of the adult population underestimates the effects of gum disease and does not follow full treatment regimens. In addition, there is also a lack of knowledge regarding the contribution of periodontal health to overall wellness, which curtails patient-generated demand for therapeutics. Closing this gap in awareness through education, digital technology, and regular follow-ups is an important challenge that may make or break treatment effectiveness and business success.
By Type
The chronic periodontal disease segment dominated the periodontal therapeutics market with a 35.16% market share in 2023 due to its high prevalence worldwide and chronic nature, requiring long-term therapeutic interventions. The most prevalent condition of chronic periodontitis among adults is a disease characterized by progressive attachment loss and alveolar bone destruction. As per the CDC, almost half of the adults who are 30 years and above exhibit signs of periodontal disease, with chronic types being the most common. The condition is usually long-term in nature and often calls for management in the form of antimicrobial therapy, scaling and root planing, and adjunctive pharmacotherapy, giving rise to the demand for therapeutic products. Further, growing awareness among dental practitioners and better diagnosis of chronic cases add to the segment's superiority.
The Gingivitis segment is anticipated to witness the fastest growth over the forecast period, led by increased awareness and preventive oral care measures. Gingivitis, which is an early, reversible form of periodontal disease, impacts a large percentage of the world population, particularly young adults and adolescents. Public health promotional campaigns focusing on early dental hygiene, improved accessibility to over-the-counter and prescription drugs, and increased demand for cosmetic oral therapeutic products are spurring high expansion in this niche. Moreover, improvements in formulations like chlorhexidine mouthwashes and herbal substitutes allow early-stage management, enhancing access and attractiveness for a wider market base.
By Drug Type
The Doxycycline segment dominated the periodontal therapeutics market with a 38.19% market share in 2023 because of its established efficacy in the treatment of periodontal infections and its dual function as an antibiotic and host-modulating agent. Doxycycline, a broad-spectrum tetracycline-class antibiotic, is extensively employed in both systemic and local formulations (e.g., subgingival delivery systems) for the treatment of chronic periodontitis. Its ability to inhibit matrix metalloproteinases (MMPs) that are responsible for tissue breakdown in periodontal disease has also made it extremely useful for long-term periodontal maintenance. The good safety profile of doxycycline, its lower level of resistance compared to other antibiotics, and the fact that it comes in sustained-release forms like doxycycline hyclate gels have also rendered it a favorite among dental professionals. The growing use of adjunctive pharmacologic therapy in addition to scaling and root planing has also driven its usage further, strengthening its market dominance in 2023.
By Distribution Channel
The Hospital Pharmacies segment dominated the periodontal therapeutics market with 43.10% market share in 2023, largely because of the increased number of dental departments within hospitals and the increasing dependence on hospital facilities for complex periodontal treatment. Hospitals tend to be the major referral centers for the treatment of complex or severe periodontal disease, particularly when it involves multidisciplinary treatments or surgery. This centralization of care stimulates greater demand for therapeutic medication via hospital pharmacies. In addition, hospital environments have a broader stock of specialized periodontal medications, including locally applied antimicrobials and host modulation treatments, to be readily available and follow treatment guidelines. Hospital pharmacies also enjoy improved procurement systems, insurance coverage procedures, and higher levels of trust among healthcare professionals, which make them the preferred channel for both prescribers and patients. All these factors combined to contribute to the supremacy of hospital pharmacies in 2023.
Regional Analysis
North America dominated the periodontal therapeutics market with a 38.07% market share in 2023, mostly due to its well-developed healthcare infrastructure, high rates of awareness about oral hygiene, and extensive availability of dental care. The region has the location of major pharmaceutical and oral care firms engaging in creating and selling solutions for the treatment of periodontal issues. In addition, regular dental check-ups, supplemented by private insurance and public health services, lead to early detection and timely intervention for periodontal disease. The incidence of periodontal diseases, especially in older adults in the U.S. and Canada, continues to demand therapeutics with efficacy.
The Asia Pacific region is experiencing the fastest growth in the periodontal therapeutics market with 8.09% CAGR over the forecast period due to rising oral health awareness, growing disposable incomes, and a rising middle-class population. China, India, and Japan are investing in the development of dental healthcare systems and increasing access to professional dental care services. Moreover, the market is also aided by growing pharmaceutical production facilities and government initiatives towards oral hygiene in rural and urban regions. As the region continues to urbanize at a high rate, changes in lifestyle and eating habits are also adding to the growing incidence of periodontal diseases, further driving market growth.
Get Customized Report as per Your Business Requirement - Enquiry Now
3M Company (Arestin, Peridex)
Haleon (Parodontax, Biotène)
Colgate-Palmolive Company (PerioGard, Colgate PerioCheck)
Procter & Gamble (Crest Gum Detoxify, Oral-B Gum Care)
GlaxoSmithKline plc (Parodontax, Corsodyl)
Sunstar Americas, Inc. (GUM Paroex, GUM Technique Deep Clean Toothbrush)
Dentsply Sirona (Oraqix, Periochip)
Pfizer Inc. (Doxycycline Hyclate, Azithromycin)
Johnson & Johnson Services, Inc. (Listerine Gum Therapy, Listerine Advanced Defence Gum Treatment)
Valeant Pharmaceuticals (now Bausch Health Companies) (Xepi, Periostat)
Zila, Inc. (Zilactin, ViziLite Plus)
Bayer AG (Baytril, PerioAid)
GC Corporation (Gluco-CheX, Cervitec Plus)
Acteon Group (Satelec Ultrasonic Scalers, Soprolife Caries Detection)
MediTeam Dental (ChlorXID, Iodoform Paste)
P&G Professional Oral Health (Crest + Oral-B) (Gum Care Mouthwash, Pro-Health Gum Detoxify)
Young Innovations, Inc. (Zooby Prophy Paste, Denticator Prophy Angle)
Septodont (Septocaine, Alveogyl)
Nobel Biocare Services AG (NobelActive Implants, GalvoSurge)
Ivoclar Vivadent AG (Cervitec F, VivaStyle Gum Protect)
Suppliers (These suppliers commonly provide active pharmaceutical ingredients (APIs), excipients, and formulation enhancers such as antimicrobial agents, binders, and stabilizers used in oral gels, rinses, and drug-delivery systems.) In the Periodontal Therapeutics Market
BASF SE
DuPont de Nemours, Inc.
Croda International Plc
Ashland Global Holdings Inc.
Evonik Industries AG
Solvay S.A.
Clariant A
DSM Nutritional Products
Lonza Group AG
Merck KGaA
September 2024 – A new dental care pathway, funded by Haleon and partnered with the National Institute for Health and Care Research (NIHR), may allow dental professionals to detect more than one million previously undiagnosed Type 2 diabetics. The program seeks to drive early case identification and incorporate screening for diabetes into a normal dental visit as part of enhanced public health.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 859.13 Million |
| Market Size by 2032 | US$ 1666.11 Million |
| CAGR | CAGR of 7.62 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others) • By Drug Type (Doxycycline, Minocycline, Chlorhexidine, Metronidazole, Other Drug Types) • By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | 3M Company, Haleon, Colgate-Palmolive Company, Procter & Gamble, GlaxoSmithKline plc, Sunstar Americas, Inc., Dentsply Sirona, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies, Zila, Inc., Bayer AG, GC Corporation, Acteon Group, MediTeam Dental, P&G Professional Oral Health, Young Innovations, Inc., Septodont, Nobel Biocare Services AG, Ivoclar Vivadent AG, and other players. |
Ans: The Periodontal Therapeutics Market is expected to grow at a CAGR of 7.62% from 2024-2032.
Ans: The Periodontal Therapeutics Market was USD 859.13 million in 2023 and is expected to reach USD 1666.11 million by 2032.
Ans: The rising prevalence of periodontal diseases across the globe is a major growth driver for the periodontal therapeutics market.
Ans: The “Doxycycline” segment dominated the Periodontal Therapeutics Market.
Ans: North America dominated the Periodontal Therapeutics Market in 2023.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Periodontal Diseases (2023)
5.2 Prescription Trends for Periodontal Therapeutics (2023), by Region
5.3 Product and Drug Type Usage Trends (2020-2032).
5.4 Healthcare Spending on Periodontal Care, by Region (2023)
5.5 Technological Advancements in Periodontal Therapeutics (2020-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Periodontal Therapeutics Market Segmentation, By Type
7.1 Chapter Overview
7.2 Gingivitis
7.2.1 Gingivitis Market Trends Analysis (2020-2032)
7.2.2 Gingivitis Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Chronic Periodontal Disease
7.3.1 Chronic Periodontal Disease Market Trends Analysis (2020-2032)
7.3.2 Chronic Periodontal Disease Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Aggressive Periodontal Disease
7.4.1 Aggressive Periodontal Disease Market Trends Analysis (2020-2032)
7.4.2 Aggressive Periodontal Disease Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
8. Periodontal Therapeutics Market Segmentation, By Drug Type
8.1 Chapter Overview
8.2 Doxycycline
8.2.1 Doxycycline Market Trends Analysis (2020-2032)
8.2.2 Doxycycline Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Minocycline
8.3.1 Minocycline Market Trends Analysis (2020-2032)
8.3.2 Minocycline Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Chlorhexidine
8.4.1 Chlorhexidine Market Trends Analysis (2020-2032)
8.4.2 Chlorhexidine Market Size Estimates and Forecasts to 2032 (USD Million)
8.5 Metronidazole
8.5.1 Metronidazole Market Trends Analysis (2020-2032)
8.5.2 Metronidazole Market Size Estimates and Forecasts to 2032 (USD Million)
8.6 Other drug types
8.6.1 Other drug types Market Trends Analysis (2020-2032)
8.6.2 Other drug types Market Size Estimates and Forecasts to 2032 (USD Million)
9. Periodontal Therapeutics Market Segmentation, By Distribution Channel
9.1 Chapter Overview
9.2 Hospital Pharmacies
9.2.1 Hospital Pharmacies Market Trends Analysis (2020-2032)
9.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Retail Pharmacies
9.3.1 Retail Pharmacies Market Trends Analysis (2020-2032)
9.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Online Channel
9.4.1 Online Channel Market Trends Analysis (2020-2032)
9.4.2 Online Channel Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.4 North America Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.2.5 North America Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.6.2 USA Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.2.6.3 USA Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.7.2 Canada Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.2.7.3 Canada Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.8.2 Mexico Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.2.8.3 Mexico Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.4 Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.5 Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.6.2 Poland Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.6.3 Poland Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.7.2 Romania Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.7.3 Romania Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.8.2 Hungary Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.8.3 Hungary Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.9.2 Turkey Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.9.3 Turkey Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.4 Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.5 Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.6.2 Germany Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.6.3 Germany Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.7.2 France Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.7.3 France Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.8.2 UK Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.8.3 UK Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.9.2 Italy Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.9.3 Italy Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.10.2 Spain Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.10.3 Spain Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.11.2 Netherlands Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.11.3 Netherlands Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.12.2 Switzerland Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.12.3 Switzerland Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.13.2 Austria Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.13.3 Austria Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.4 Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.5 Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.6.2 China Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.6.3 China Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.7.2 India Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.7.3 India Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.8.2 Japan Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.8.3 Japan Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.9.2 South Korea Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.9.3 South Korea Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.10.2 Vietnam Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.10.3 Vietnam Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.11.2 Singapore Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.11.3 Singapore Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.12.2 Australia Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.12.3 Australia Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.4 Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.5 Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.6.2 UAE Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.6.3 UAE Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.7.2 Egypt Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.7.3 Egypt Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.9.2 Qatar Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.9.3 Qatar Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.4 Africa Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.2.5 Africa Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.6.2 South Africa Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.2.6.3 South Africa Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.7.2 Nigeria Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.2.7.3 Nigeria Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.4 Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.6.5 Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.6.2 Brazil Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.6.6.3 Brazil Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.7.2 Argentina Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.6.7.3 Argentina Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.8.2 Colombia Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.6.8.3 Colombia Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Drug Type (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America Periodontal Therapeutics Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)
11. Company Profiles
11.1 3M Company
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Haleon
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Colgate-Palmolive Company
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Procter & Gamble
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Sunstar Americas, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Dentsply Sirona
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Pfizer Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Johnson & Johnson Services, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Valeant Pharmaceuticals
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Type
By Drug Type
By Distribution Channel
Request for Segment Customization as per your Business Requirement: https://www.snsinsider.com/enquiry/6765
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: https://www.snsinsider.com/enquiry/6765
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
The Filter Integrity Test Market was valued at USD 83.08 million in 2023 and is expected to reach USD 126.79 million by 2032, growing at a CAGR of 4.86% from 2024-2032.
Pet Grooming Services Market Size was valued at USD 6.33 Billion in 2023 and is expected to reach USD 12.05 Billion by 2032, growing at a CAGR of 7.42% over the forecast period 2024-2032.
The Medical Ceramics Market Size was valued at USD 20.2 billion in 2023, and is expected to reach USD 31.63 billion by 2032, and grow at a CAGR of 5.11% over the forecast period 2024-2032.
The Pediatric Clinical Trials Market was valued at USD 21.49 billion in 2023 and is expected to reach USD 28.63 billion by 2032, growing at a CAGR of 4.30% from 2024 to 2032.
The Antimicrobial Resistance Surveillance Market was valued at USD 5.90 Billion in 2023 and is projected to grow to USD 9.50 billion by 2032 with a CAGR of 5.47% over the forecast period 2024-2032.
The Dental 3D Printing Market size was USD 3.2 billion in 2023 and is projected to grow to USD 17.7 billion by 2032, with a CAGR of 21% during 2024-2032
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
